73 related articles for article (PubMed ID: 15208163)
1. Advanced glycation end-products in patients with chronic alcohol misuse.
Kalousová M; Zima T; Popov P; Spacek P; Braun M; Soukupová J; Pelinkova K; Kientsch-Engel R
Alcohol Alcohol; 2004; 39(4):316-20. PubMed ID: 15208163
[TBL] [Abstract][Full Text] [Related]
2. Plasma advanced glycation end products are decreased in obese children compared with lean controls.
Sebeková K; Somoza V; Jarcusková M; Heidland A; Podracká L
Int J Pediatr Obes; 2009; 4(2):112-8. PubMed ID: 18645732
[TBL] [Abstract][Full Text] [Related]
3. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
[TBL] [Abstract][Full Text] [Related]
4. Decreased levels of advanced glycation end-products in patients with Gilbert syndrome.
Kalousová M; Novotny L; Zima T; Braun M; Vítek L
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(4):387-92. PubMed ID: 16309589
[TBL] [Abstract][Full Text] [Related]
5. The association of advanced glycation end-products with glutathione status.
Sahin E; Göçmen AY; Koçak H; Tuncer M; Gümüslü S
Ann Clin Biochem; 2008 Jul; 45(Pt 4):369-74. PubMed ID: 18583621
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of advanced glycation end products in children with renal disease.
Sebeková K; Podracká L; Blazícek P; Syrová D; Heidland A; Schinzel R
Pediatr Nephrol; 2001 Dec; 16(12):1105-12. PubMed ID: 11793110
[TBL] [Abstract][Full Text] [Related]
7. Alcohol misuse increases serum antibodies to oxidized LDL and C-reactive protein.
Alho H; Sillanaukee P; Kalela A; Jaakkola O; Laine S; Nikkari ST
Alcohol Alcohol; 2004; 39(4):312-5. PubMed ID: 15208162
[TBL] [Abstract][Full Text] [Related]
8. Short-term low calorie diet intervention reduces serum advanced glycation end products in healthy overweight or obese adults.
Gugliucci A; Kotani K; Taing J; Matsuoka Y; Sano Y; Yoshimura M; Egawa K; Horikawa C; Kitagawa Y; Kiso Y; Kimura S; Sakane N
Ann Nutr Metab; 2009; 54(3):197-201. PubMed ID: 19420913
[TBL] [Abstract][Full Text] [Related]
9. Associations of serum levels of advanced glycation end products with nutrition markers and anemia in patients with chronic kidney disease.
Kratochvilová M; Zakiyanov O; Kalousová M; Kříha V; Zima T; Tesař V
Ren Fail; 2011; 33(2):131-7. PubMed ID: 21332333
[TBL] [Abstract][Full Text] [Related]
10. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
[TBL] [Abstract][Full Text] [Related]
11. Effect of high-dose thiamine and pyridoxine on advanced glycation end products and other oxidative stress markers in hemodialysis patients: a randomized placebo-controlled study.
Nascimento MM; Suliman ME; Murayama Y; Nihi M; Hayashi SY; Stenvinkel P; Riella MC; Lindholm B
J Ren Nutr; 2006 Apr; 16(2):119-24. PubMed ID: 16567267
[TBL] [Abstract][Full Text] [Related]
12. Does renal function influence plasma levels of advanced glycation and oxidation protein products in patients with chronic rheumatic diseases complicated by secondary amyloidosis?
Rysavá R; Kalousová M; Zima T; Dostál C; Merta M; Tesar V
Kidney Blood Press Res; 2007; 30(1):1-7. PubMed ID: 17191033
[TBL] [Abstract][Full Text] [Related]
13. Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis.
Fragedaki E; Nebel M; Schupp N; Sebekova K; Völkel W; Klassen A; Pischetsrieder M; Frischmann M; Niwa T; Vienken J; Heidland A; Stopper H
Nephrol Dial Transplant; 2005 Sep; 20(9):1936-43. PubMed ID: 15919695
[TBL] [Abstract][Full Text] [Related]
14. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure.
Witko-Sarsat V; Friedlander M; Nguyen Khoa T; Capeillère-Blandin C; Nguyen AT; Canteloup S; Dayer JM; Jungers P; Drüeke T; Descamps-Latscha B
J Immunol; 1998 Sep; 161(5):2524-32. PubMed ID: 9725252
[TBL] [Abstract][Full Text] [Related]
15. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
Tekin IO; Pocan B; Borazan A; Ucar E; Kuvandik G; Ilikhan S; Demircan N; Ozer C; Kadayifci S
Ren Fail; 2008; 30(2):219-25. PubMed ID: 18300125
[TBL] [Abstract][Full Text] [Related]
16. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
Meerwaldt R; Hartog JW; Graaff R; Huisman RJ; Links TP; den Hollander NC; Thorpe SR; Baynes JW; Navis G; Gans RO; Smit AJ
J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473
[TBL] [Abstract][Full Text] [Related]
17. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
[TBL] [Abstract][Full Text] [Related]
18. Relationship between proinsulin-to-insulin ratio and advanced glycation endproducts in Japanese type 2 diabetic subjects.
Saisho Y; Maruyama T; Hirose H; Saruta T
Diabetes Res Clin Pract; 2007 Nov; 78(2):182-8. PubMed ID: 17467843
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysis.
Roberts MA; Thomas MC; Fernando D; Macmillan N; Power DA; Ierino FL
Nephrol Dial Transplant; 2006 Jun; 21(6):1611-7. PubMed ID: 16520354
[TBL] [Abstract][Full Text] [Related]
20. A novel advanced glycation index and its association with diabetes and microangiopathy.
Sampathkumar R; Balasubramanyam M; Rema M; Premanand C; Mohan V
Metabolism; 2005 Aug; 54(8):1002-7. PubMed ID: 16092048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
